Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022

SELL
$6.28 - $15.59 $129,631 - $321,808
-20,642 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$14.7 - $28.67 $156,966 - $306,138
10,678 Added 107.17%
20,642 $316,000
Q3 2021

Nov 09, 2021

BUY
$24.31 - $33.6 $43,539 - $60,177
1,791 Added 21.91%
9,964 $283,000
Q2 2021

Sep 01, 2021

SELL
$26.09 - $40.4 $68,877 - $106,656
-2,640 Reduced 24.42%
8,173 $276,000
Q1 2021

May 13, 2021

BUY
$33.06 - $56.93 $357,477 - $615,584
10,813 New
10,813 $413,000
Q3 2020

Nov 04, 2020

SELL
$28.43 - $44.67 $1.6 Million - $2.52 Million
-56,416 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$11.71 - $30.29 $660,631 - $1.71 Million
56,416 New
56,416 $1.71 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.